Phase II, multicenter, open-label, non-comparative, non-randomized study with three-stage design
Phase II, multicenter, open-label, non-comparative, non-randomized study with three-stage design
NCT04427787
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
19 February 2024
Congrats! You have your own personal workspace now.